Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response — which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- Mayo Clinic neurosurgeon reveals 8 back pain myths to stop believing
- Indoor tanning triples melanoma risk and seeds broad DNA mutations
- Gene-edited CAR-T cells erase aggressive T-cell leukemia
- Blood tests reveal obesity rapidly accelerates Alzheimer’s progression
- Scientists say this viral rosemary skincare trend actually works
- Gas stoves are filling millions of homes with hidden toxic air
- A routine shingles shot may offer powerful defense against dementia
- Your skin has a built-in cancer defense and sunlight turns it off
- RSV prevention in newborns could cut asthma risk
- Scientists discover hidden wolf DNA in most dogs
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
